Project Details
Description
Central hypothesis is that nanotechnology strategies can provide effective solutions to current challenges in brain drug delivery to significantly delay disease progression and extend survival in patients with brain diseases including, but not restricted to, brain cancer and Alzheimer’s disease (AD).
| Status | Active |
|---|---|
| Effective start/end date | 1/01/21 → 31/12/25 |